AlphaYouBV
Schedule 13G filing
BIOTECHNOLOGY VALUE FUND L P disclosed a 6.1% stake in Tyra Biosciences, Inc. (TYRA)
BIOTECHNOLOGY VALUE FUND L P reported owning 6.1% of Tyra Biosciences, Inc. (TYRA) (4,215,886 shares) in a Schedule 13G filed Sep 21, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 21, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.